Pegylated Liposomal Doxorubicin (PLD) Versus Active Surveillance for Advanced Soft Tissue Sarcoma Patients Who Had Controlled Disease After Standard Anthracycline-based Treatment (MELODY)
Clinical trial NCT06981637 · RECRUITING
Trial details
- NCT number
- NCT06981637
- Sponsor
- National Health Research Institutes, Taiwan
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2028-07-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.